Jean L. Oosthuizen

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green et al. · Gastroenterology · 2016 · 135 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial

Gary T. Ferguson, J. Mark FitzGerald, Eugene R. Bleecker et al. · The Lancet Respiratory Medicine · 2017 · 123 citations

Pharmacy, Pharmacology, Pharmacotherapy +7

Dual Organism Transcriptomics of Airway Epithelial Cells Interacting with Conidia of Aspergillus fumigatus

Jean L. Oosthuizen, Pol Gomez, Jian Ruan et al. · PLoS ONE · 2011 · 73 citations · Full text

Life Sciences, Microbiology, Molecular Biology +12

Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge

Amrit Singh, Gabriela V. Cohen Freue, Jean L. Oosthuizen et al. · PROTEOMICS - CLINICAL APPLICATIONS · 2012 · 11 citations

Life Sciences, Immunology, Molecular Biology +17